arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

AVITA Medical, Inc.

RCEL

$7.76 ▲ +3.04 (+64.41%) at close

10 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

AVITA Medical, Inc. shows mixed fundamentals. However, watch Profit Margin (%) which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $216.2M

Dividend Yield —

Revenue Growth 11.5% ↘

Op. Margin -59.4% ↗

ROIC 255.5% ↗

FCF / Share $-1.16 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity 0.00

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$71.61M

↑ +11.5% —

Net Income Profit after all expenses

$-48.59M

↑ +21.4% —

Operating Margin Operating profit as % of sales

-59.4%

↑ +32.6% 4th

FCF / Share Free cash flow per share

$-1.16

↑ +48.5% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

100

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Jun 30, 2021 10-K ↗	FY 2019 Jun 30, 2020 10-K ↗	FY 2018 Jun 30, 2019 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗	FY 2016 Jun 30, 2017 10-K ↗
Revenue Growth YoY (%)	11.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+43%)	28.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+252%)	45.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+471%)	—	—	104.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1212%)	160.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1907%)	489.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6015%)	—	—
EPS Growth YoY (%)	27.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-70.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	-43.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	13169.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	13.9% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	21.4% Good ↑ Good Improving Year-over-year change in net income	-74.8% Weak Weak Year-over-year change in net income	-32.7% Weak Weak Year-over-year change in net income	—	—	36.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-67.4% Weak Weak Year-over-year change in net income	-97.1% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	48.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-44.4% Weak Weak Year-over-year change in free cash flow	-98.9% Weak Weak Year-over-year change in free cash flow	—	—	-2.7% Weak ↑ Weak Improving Year-over-year change in free cash flow	-9014.6% Weak Weak Year-over-year change in free cash flow	11.7% Fair Fair Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	27.7% Excellent → Excellent Stable Compound annual revenue growth over 3 years	—	19.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	34.1% Excellent Excellent Compound annual revenue growth over 3 years	—	215.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	19.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	35.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	55.7% Excellent Excellent Compound annual revenue growth over 5 years	105.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	-19.7% Weak Weak Compound annual EPS growth over 3 years	—	340.4% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Jun 30, 2021 10-K ↗	FY 2019 Jun 30, 2020 10-K ↗	FY 2018 Jun 30, 2019 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗	FY 2016 Jun 30, 2017 10-K ↗
Operating Margin (%) (%)	-59.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-496%)	-88.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-687%)	-85.1% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-667%)	-79.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-633%)	—	-90.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-705%)	-299.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2095%)	-466.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3209%)	—	—
Effective Tax Rate (%) (%)	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-67.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-665%)	-96.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-902%)	-70.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-688%)	-77.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-746%)	—	-90.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-858%)	-294.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2556%)	-458.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3921%)	—	—
FCF Margin (%) (%)	-45.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-90.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-78.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-56.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-91.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-163.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-370.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Jun 30, 2021 10-K ↗	FY 2019 Jun 30, 2020 10-K ↗	FY 2018 Jun 30, 2019 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗	FY 2016 Jun 30, 2017 10-K ↗
Return on Invested Capital (%)	255.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-121.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-23.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-59.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-122.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-91.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-75.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-21.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-99.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	291.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1845%)	—	-72.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-581%)	-31.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-310%)	—	-23.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-58.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-487%)	-120.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-903%)	-90.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-705%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Jun 30, 2021 10-K ↗	FY 2019 Jun 30, 2020 10-K ↗	FY 2018 Jun 30, 2019 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗	FY 2016 Jun 30, 2017 10-K ↗
Debt to Equity (x)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	9.39x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1465%)	0.81x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+35%)	—	—	—	—	—	—	—
Interest Coverage (x)	-8.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-37.32x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1719.06x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-1206.36x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1293.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-945.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	-659.10x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-10.24M	$28.20M	$17.69M	$-18.16M	$-55.51M	$-110.75M	$-73.64M	$-20.17M	—	—
Debt / EBITDA (x)	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.76x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.95x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Jun 30, 2021 10-K ↗	FY 2019 Jun 30, 2020 10-K ↗	FY 2018 Jun 30, 2019 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗	FY 2016 Jun 30, 2017 10-K ↗
Revenue per Share (USD)	$2.57	$2.48	$1.98	$1.38	—	$1.29	$0.70	$0.00	$0.00	—
Basic EPS, GAAP (USD)	$-1.74	$-2.39	$-1.40	$1.07	—	$1.17	$2.07	$0.02	$0.01	—
Free Cash Flow per Share (USD)	$-1.16	$-2.25	$-1.56	$-0.78	—	$-1.18	$-1.15	$-0.01	$-0.01	—
Book Value per Share (USD)	$-0.54	$0.17	$1.91	$3.36	$4.20	$4.65	$3.37	$0.01	$0.02	—
Tangible Book Value per Share (USD)	$-0.73	$-0.04	$1.89	$3.34	$4.18	$4.63	$3.36	$0.01	$0.02	—
Basic Weighted Avg Shares (shares)	27.86M	25.88M	25.33M	25.00M	—	22.67M	20.29M	1.61B	932.68M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Jun 30, 2021 10-K ↗	FY 2019 Jun 30, 2020 10-K ↗	FY 2018 Jun 30, 2019 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗	FY 2016 Jun 30, 2017 10-K ↗
Working Capital (USD)	$-27.19M	$36.84M	$90.81M	$76.77M	$82.99M	$113.94M	$70.68M	$19.64M	—	—
LT Debt (USD)	$0.00	$42.24M	$39.81M	—	—	—	—	—	—	—
Total Equity (USD)	$-16.65M	$4.50M	$49.06M	$84.74M	$104.62M	$115.66M	$72.40M	$20.83M	$14.03M	$3.93M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Jun 30, 2021 10-K ↗	FY 2019 Jun 30, 2020 10-K ↗	FY 2018 Jun 30, 2019 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗	FY 2016 Jun 30, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$71.61M	$64.25M	$50.14M	$34.42M	—	$29.23M	$14.26M	$5.47M	$929.00K	—
Depreciation Expense (USD)	$2.35M	$1.13M	$632.00K	$568.00K	—	$715.00K	$465.00K	$269.00K	$110.00K	—
Net Income, GAAP (USD)	$-48.59M	$-61.84M	$-35.38M	$-26.66M	—	$-26.58M	$-42.03M	$-25.10M	$-12.73M	—
Operating Cash Flow (USD)	$-31.20M	$-48.94M	$-38.01M	$-19.09M	—	$-25.90M	$-22.75M	$-19.25M	$-12.96M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 32 quarters

AVITA Medical, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RCEL with peers